{"id":789162,"date":"2023-10-10T07:35:08","date_gmt":"2023-10-10T11:35:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/"},"modified":"2023-10-10T07:35:08","modified_gmt":"2023-10-10T11:35:08","slug":"date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/","title":{"rendered":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOCA RATON, Fla., Oct.  10, 2023  (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein\u2019s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco.<\/p>\n<p align=\"justify\">In addition to the presentation, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors at the conference, showcasing the company\u2019s business and clinical development strategy, recent corporate achievements, and anticipated milestones.<\/p>\n<p align=\"justify\">Details of the presentation are as follows:<\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Event:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">2023 BIO Investor Forum<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Presentation:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">First Wave BioPharma Company Overview and Updates &#8211; Chairman, President, and CEO James Sapirstein<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Date\/Time:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">Tuesday, October 17, 2023; 11:15 a.m. PDT<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>Location:<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;text-align: justify;vertical-align: middle;vertical-align: top\">The Hilton San Francisco, 333 O\u2019Farrell Street, San Francisco, CA<br \/>The Franciscan B Room<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About First Wave BioPharma, Inc.<\/strong><br \/>\n        <br \/>First Wave BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company is currently advancing a therapeutic development pipeline with multiple Phase 2 clinical stage programs built around three proprietary technologies \u2013 the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency; capeserod, a selective 5-HT4 receptor partial agonist which First Wave will pursue for gastrointestinal (GI) indications; and niclosamide, an oral small molecule with anti-inflammatory properties for patients with inflammatory bowel diseases such as ulcerative colitis and Crohn\u2019s disease. First Wave BioPharma is headquartered in Boca Raton, Florida. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DYGaaYaFnzVVY4PkcCzol_7GaEI5YgW_j2B-STNDnte0NLvwqgPWsKaxZQn-Sxf-V7BtVzo7ZdmVxdCrDEn1vm_MucsHAGEFBvWpRX82MvA=\" rel=\"nofollow noopener\" target=\"_blank\">www.firstwavebio.com<\/a>.<\/p>\n<p>\n        <strong>For more information:<\/strong><br \/>\n        <br \/>First Wave BioPharma, Inc.<br \/>777 Yamato Road, Suite 502<br \/>Boca Raton, FL 33431<br \/>Phone: (561) 589-7020<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yp-Jq06vva4NmzjetvRQPr4TcA6JFK-XM8e3tycjJqWJSvnhoHC-9ZJefZWsP7lhJkX6NdAC4Oc7-O-9nvaDpcbMsCf8Yi8HVTXjs59PVqc=\" rel=\"nofollow noopener\" target=\"_blank\">info@firstwavebio.com<\/a><\/p>\n<p>\n        <strong>Media contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nU2cUIZTY8JRH-2Js7ozrRAZeI31ohhg-Togj34K76ILBhmTzHDesVIhvUZUuNcPeAq8MInTecP2X9YSDil-MguEH6bHUH7hFwS4_kyitj4=\" rel=\"nofollow noopener\" target=\"_blank\">Tiberend Strategic Advisors, Inc.<\/a><br \/>\n        <br \/>David Schemelia<br \/>(609) 468-9325<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YvYuPt6nbOwkVpRwTRcgALiM52OoTHbYX4hKDee1eThYBqW-qMgBild_LDeuzj5INOls3SkSgc2_ZasGlCleq3tqpZLRHeEMUyXyagQuvdk=\" rel=\"nofollow noopener\" target=\"_blank\">dschemelia@tiberend.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2I5ZWY1ZjAtN2Q5Ny00NmNlLTg3OTQtMzVmYjgwZGRmMWQyLTEwOTM3Nzg=\/tiny\/First-Wave-BioPharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein\u2019s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco. In addition to the presentation, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors at the conference, showcasing the company\u2019s business and clinical development strategy, recent corporate achievements, and anticipated milestones. Details of the presentation are as &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789162","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein\u2019s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco. In addition to the presentation, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors at the conference, showcasing the company\u2019s business and clinical development strategy, recent corporate achievements, and anticipated milestones. Details of the presentation are as &hellip; Continue reading &quot;Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-10T11:35:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum\",\"datePublished\":\"2023-10-10T11:35:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/\"},\"wordCount\":335,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/\",\"name\":\"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\",\"datePublished\":\"2023-10-10T11:35:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk","og_description":"BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) &#8212; First Wave BioPharma, Inc., (NASDAQ: FWBI), (\u201cFirst Wave BioPharma\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for\u00a0gastrointestinal (GI) diseases, today announced that Chairman, President, and CEO of First Wave BioPharma James Sapirstein\u2019s presentation at the 2023 BIO Investor Forum will take place at 11:15 a.m. PDT on October 17, 2023 in the Franciscan B Room at the Hilton San Francisco. In addition to the presentation, members of the First Wave BioPharma management team will conduct one-on-one meetings with registered investors at the conference, showcasing the company\u2019s business and clinical development strategy, recent corporate achievements, and anticipated milestones. Details of the presentation are as &hellip; Continue reading \"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-10T11:35:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum","datePublished":"2023-10-10T11:35:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/"},"wordCount":335,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/","name":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=","datePublished":"2023-10-10T11:35:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODk0NTE0NCM1ODYxMjcxIzIwODIyMDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/date-and-time-announced-for-first-wave-biopharma-ceo-james-sapirsteins-presentation-at-the-2023-bio-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Date and Time Announced for First Wave BioPharma CEO James Sapirstein\u2019s Presentation at the 2023 BIO Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789162"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789162\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}